Moexipril Hydrochloride (Glenmark Pharmaceuticals Inc., USA)
Welcome to the PulseAid listing for the Moexipril Hydrochloride drug offered from Glenmark Pharmaceuticals Inc., USA. This Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Glenmark Pharmaceuticals Inc., USA |
| NON-PROPRIETARY NAME: | Moexipril Hydrochloride |
| SUBSTANCE NAME: | MOEXIPRIL HYDROCHLORIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Angiotensin Converting Enzyme Inhibitor [EPC],Angiotensin-converting Enzyme Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2010-12-31 |
| END MARKETING DATE: | 0000-00-00 |
Moexipril Hydrochloride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Moexipril Hydrochloride from Glenmark Pharmaceuticals Inc., USA |
| LABELER NAME: | Glenmark Pharmaceuticals Inc., USA |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 15(mg/1) |
| START MARKETING DATE: | 2010-12-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 68462-208_48c27a72-1dc6-44a3-8676-c9cd3fa7048b |
| PRODUCT NDC: | 68462-208 |
| APPLICATION NUMBER: | ANDA090416 |
Other MOEXIPRIL HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:
